JPH09510688A - Ｃｘｃインタークリン分子のペプチド阻害剤 - Google Patents

Ｃｘｃインタークリン分子のペプチド阻害剤

Info

Publication number
JPH09510688A
JPH09510688A JP7516716A JP51671695A JPH09510688A JP H09510688 A JPH09510688 A JP H09510688A JP 7516716 A JP7516716 A JP 7516716A JP 51671695 A JP51671695 A JP 51671695A JP H09510688 A JPH09510688 A JP H09510688A
Authority
JP
Japan
Prior art keywords
peptide
arg
seq
amino acid
composition comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7516716A
Other languages
English (en)
Japanese (ja)
Inventor
コーエン，アレン・バリー
ミラー，エドマンド・ジェイ
真一郎 林
クルドウスカ，アンナ・ケイ
タトゥル，ロナルド・アール
Original Assignee
ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム filed Critical ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム
Publication of JPH09510688A publication Critical patent/JPH09510688A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP7516716A 1993-12-15 1993-12-15 Ｃｘｃインタークリン分子のペプチド阻害剤 Pending JPH09510688A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/012245 WO1995016702A1 (en) 1993-12-15 1993-12-15 Peptide inhibitors of cxc intercrine molecules

Publications (1)

Publication Number Publication Date
JPH09510688A true JPH09510688A (ja) 1997-10-28

Family

ID=22237305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7516716A Pending JPH09510688A (ja) 1993-12-15 1993-12-15 Ｃｘｃインタークリン分子のペプチド阻害剤

Country Status (7)

Country Link
EP (1) EP0734394A1 (no)
JP (1) JPH09510688A (no)
KR (1) KR100290224B1 (no)
AU (1) AU685079B2 (no)
FI (1) FI962413A (no)
NO (1) NO962549L (no)
WO (1) WO1995016702A1 (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007039702A (ja) * 1996-12-26 2007-02-15 Nippon Shokubai Co Ltd 樹脂粒子の製造方法
CN112996528A (zh) * 2018-09-11 2021-06-18 安必圣有限责任公司 肽及其医学用途

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110889A (en) * 1996-06-14 2000-08-29 Board Of Regents, The University Of Texas System Peptide tumor cell growth inhibitors
CN103524602B (zh) * 2013-10-30 2015-04-08 重庆市畜牧科学院 抗菌肽在制药中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5632988A (en) * 1989-10-23 1997-05-27 Schering Corporation Polypeptide inhibitors of gamma interferon
US5079228A (en) * 1990-02-05 1992-01-07 Board Of Regents, The University Of Texas System Peptide inhibitors of neutrophil activating factor induced chemotaxis
DK0558671T3 (da) * 1990-11-21 1999-09-13 Iterex Pharma Lp Syntese af ækvimolære multiple oligomerblandinger, især af oligopeptidblandinger

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007039702A (ja) * 1996-12-26 2007-02-15 Nippon Shokubai Co Ltd 樹脂粒子の製造方法
JP4704317B2 (ja) * 1996-12-26 2011-06-15 株式会社日本触媒 樹脂粒子の製造方法
CN112996528A (zh) * 2018-09-11 2021-06-18 安必圣有限责任公司 肽及其医学用途

Also Published As

Publication number Publication date
KR100290224B1 (ko) 2001-05-15
FI962413A0 (fi) 1996-06-11
AU6014794A (en) 1995-07-03
WO1995016702A1 (en) 1995-06-22
NO962549L (no) 1996-08-14
KR960706503A (ko) 1996-12-09
AU685079B2 (en) 1998-01-15
FI962413A (fi) 1996-07-24
NO962549D0 (no) 1996-06-14
EP0734394A1 (en) 1996-10-02

Similar Documents

Publication Publication Date Title
KR100248033B1 (ko) 사이토킨 억제제
KR100242597B1 (ko) 혈액-뇌 장벽 투과성을 증가시키는 투과제 펩티드
KR101479148B1 (ko) 주형 고정된 펩타이드 모방체
KR20120123654A (ko) 멜라노코르틴-1 수용체 특이적 고리형 펩티드
EP2552470B1 (en) Peptides for promoting angiogenesis and an use thereof
US8765673B2 (en) Methods for promoting wound healing and/or reducing scar formation
US6355619B1 (en) Peptide tumor cell growth inhibitors
US5965536A (en) Methods of inhibiting CXC intercrine molecules
CN111423502A (zh) 多肽、其衍生物及其在制备抗肺纤维化的药物中的应用
EP1781315B1 (en) Peptide inhibitors for mediating stress responses
US5624902A (en) Peptide inhibitors of calmodulin
JPH09510688A (ja) Ｃｘｃインタークリン分子のペプチド阻害剤
WO1996009062A1 (en) Polypeptide agonists and antagonists of human interleukin-8
US5627156A (en) Polypeptide agonists for human interleukin-8
US10143718B2 (en) Covalent inhibitors of dual oxidase 1 (DUOX 1)
US6017883A (en) Composition and methods for the inhibition of phagocytes
US20210113652A1 (en) Maspin-based inhibition of osteoclast activity and promotion of bone formation
US8076453B2 (en) Kinin B1 receptor peptide agonists and uses thereof
WO2014075137A1 (en) Peptides incorporating amino-substituted lactams for treatment of retinopathy
CA2178927A1 (en) Peptide inhibitors of cxc intercrine molecules
CN116139247A (zh) 一类订书肽化合物在制备治疗肺纤维化的药物中的应用
WO2019067887A1 (en) ENAC INHIBITOR PEPTIDES AND USES THEREOF
WO1999015561A1 (en) Inhibitors of hematopoietins interleukin-3, interleukin-5 and granulocyte/macrophage colony stimulating factor and uses thereof

Legal Events

Date Code Title Description
A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20031201

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040115

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050726